98%
921
2 minutes
20
Fontan pathway obstruction is a potentially serious complication characterized by an anatomical or functional narrowing anywhere in the cavo-pulmonary pathways. Here, we report the first case in the literature where an innovative Fontan conduit rehabilitation procedure with intravascular lithotripsy was used achieving a dramatic increase in the pathway size.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11068967 | PMC |
http://dx.doi.org/10.1016/j.jaccas.2024.102296 | DOI Listing |
Cardiol J
September 2025
Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Background: Cumulative data has highlighted the efficacy of intra-vascular lithotripsy (IVL) in patients with stent failure (SF). However, it remains unclear whether the effectiveness of IVL, and subsequent clinical outcomes, are influenced by the timing of SF. We aimed to evaluate the outcomes of patients with SF undergoing IVL according to the age of index stent implantation.
View Article and Find Full Text PDFKardiol Pol
September 2025
Department of Cardiology, Interventional Electrocardiology and Hypertension, University Hospital, Kraków, Poland.
BMC Cardiovasc Disord
September 2025
Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, Ostrava, Czech Republic.
Background: This prospective randomized study compares the efficacy of novel intravascular lithotripsy (IVL) to the standard preparation of calcified coronary lesions based on rotational atherectomy (RA).
Methods: A total of 50 patients with 52 calcified lesions were enrolled in the study and randomized 1:1 to be treated with IVL or RA followed by drug-eluting stent (DES) implantation. The procedural success was chosen as a primary endpoint and the 12-month late lumen loss (LLL) as measured by quantitative coronarography, the incidence of binary in-stent restenosis (ISR), 12-month major adverse cardiac events (MACE) and target lesion failure (TLF) served as secondary angiographic and clinical endpoints.
JACC Adv
September 2025
Cardiovascular Institute, Detroit Medical Center, Wayne State University, DMC Heart Hospital, Detroit, Michigan, USA. Electronic address:
Background: Disparities in health care access persist in cardiovascular interventions. Coronary lithotripsy, a novel treatment for calcified coronary lesions, shows variability in utilization by sociodemographic factors.
Objectives: This study examines the impact of sex, race, income, and hospital characteristics on lithotripsy use in the United States.
Struct Heart
August 2025
Cardiology Department, Bichat Claude Bernard Hospital, Paris, France.